PUMA BIOTECHNOLOGY, INC.·4

Feb 14, 5:54 PM ET

HUNT DOUGLAS M 4

4 · PUMA BIOTECHNOLOGY, INC. · Filed Feb 14, 2024

Insider Transaction Report

Form 4
Period: 2024-02-12
HUNT DOUGLAS M
See Remarks
Transactions
  • Award

    Common Stock

    2024-02-12+37,894141,213 total
  • Award

    Stock Option (Right to Buy)

    2024-02-12+52,45252,452 total
    Exercise: $6.36Exp: 2034-02-11Common Stock (52,452 underlying)
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date.
  • [F2]Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4